Pricing Log in Create free account

CytomX Therapeutics, Inc. (CTMX) vs REGENXBIO Inc. (RGNX)

CytomX Therapeutics, Inc. and REGENXBIO Inc. are both Biotechnology companies. CytomX Therapeutics, Inc. and REGENXBIO Inc. are of similar size ($487.2M and $466.3M). REGENXBIO Inc. grew revenue faster over the last twelve months: −4.59% against −87.7%. REGENXBIO Inc. has the higher net margin (−113.9% vs −630.4%) and the higher return on invested capital (0.00% vs −20.8%). Across the 17 metrics below, REGENXBIO Inc. leads on 10 and CytomX Therapeutics, Inc. on 7.

Valuation

Metric CTMX RGNX Biotechnology median
P/E n/m n/m 10.60
P/S 34.21 3.21 9.40
P/B 1.68 3.33 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 10.89 1.61 9.02
Earnings yield (22.83%) (42.52%) (32.88%)
Free cash flow yield (10.61%) (31.38%) (23.13%)

Profitability

Metric CTMX RGNX Biotechnology median
Gross margin 100.00% 87.54% 68.51%
Operating margin (676.45%) (95.68%) 0.00%
Net margin (630.38%) (113.85%) 0.00%
Free cash flow margin (362.89%) (100.58%) 0.00%
Return on equity (45.08%) (113.24%) (51.96%)
Return on assets (33.82%) (35.36%) (46.06%)
Return on invested capital (20.82%) 0.00% 0.00%

Growth

Metric CTMX RGNX Biotechnology median
Revenue growth (TTM) (87.66%) (4.59%) 6.76%
EPS growth (last fiscal year) (139.47%) 18.08% 29.88%
Revenue growth, 5-year CAGR (5.36%) 1.97% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTMX RGNX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.82 4.74 4.97
Net debt to EBITDA 5.91 1.58 1.01

Dividend

Metric CTMX RGNX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CTMX RGNX Biotechnology median
Market cap 466.30m 487.18m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack